Loading...
XNAS
PRCT
Market cap1.19bUSD
Jul 10, Last price  
20.89USD
1D
-0.23%
1Q
-14.87%
IPO
-45.00%
Name

PROCEPT BioRobotics Corp

Chart & Performance

D1W1MN
XNAS:PRCT chart
P/E
P/S
3.86
EPS
Div Yield, %
Shrs. gr., 5y
9.59%
Rev. gr., 5y
109.04%
Revenues
308m
+37.22%
6,169,0007,717,00034,473,00075,014,000136,191,000224,498,000308,054,000
Net income
-96m
L+4.55%
-41,975,000-53,019,000-59,853,000-87,154,000-105,897,000-91,413,000-95,572,000
CFO
-49m
L-50.63%
-43,818,000-48,343,000-57,334,000-80,382,000-108,003,000-99,213,000-48,985,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
IPO date
Sep 15, 2021
Employees
428
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT